EPA and CO2: Bills introduced to block EPA regulation

From the Washington Post:
On Thursday, Sen. John D. Rockefeller IV (D-W.Va.) introduced a bill that would put a two-year freeze on the EPA's ability to regulate greenhouse gases from power plants. His was the latest of various congressional proposals -- from both chambers and both parties -- designed to delay or overturn the EPA's regulations . . . Rockefeller's legislation would not affect the EPA's plans to limit greenhouse gas emissions from cars and trucks. But it would prevent the agency from implementing -- or even doing much work on -- caps on emissions from such "stationary sources" as power plants and factories. Experts say the bill could postpone regulations for as much as four years. 
He's protecting the West Virginia coal industry, of course. But other bills are also being offered . . .
Sens. Blanche Lincoln (D-Ark.), Mary Landrieu (D-La.) and Ben Nelson (D-Neb.) are co-sponsoring a "resolution of disapproval" introduced by Sen. Lisa Murkowski (R-Alaska). It calls for Congress to overturn the EPA's finding that greenhouse gases are a danger to public health and welfare, the trigger for the agency's efforts to regulate them. In the House, Agriculture Committee Chairman Collin C. Peterson (D-Minn.) and Armed Services Committee Chairman Ike Skelton (D-Mo.) have introduced a measure similar to Murkowski's. Rep. Earl Pomeroy (D-N.D.) proposes to strip the EPA of its authority to regulate pollution linked to global warming. And House Natural Resources Committee Chairman Nick J. Rahall II (D-W.Va.) and Reps. Alan B. Mollohan (W.Va.) and Rick Boucher (D-Va.) have said they will introduce a companion bill to Rockefeller's.

Comments

Post a Comment

Popular posts from this blog

Healthcare: HSAs work!

Via Carpe Diem: In 2009, for example, state workers with the HSA visited emergency rooms and physicians 67% less frequently than co-workers with traditional health care. They were much more likely to use generic drugs than those enrolled in the conventional plan, resulting in an average lower cost per prescription of $18. They were admitted to hospitals less than half as frequently as their colleagues. Differences in health status between the groups account for part of this disparity, but consumer decision-making is, we've found, also a major factor. Overall, participants in our new plan ran up only $65 in cost for every $100 incurred by their associates under the old coverage.
Read more